WuXi Receives 2015 Open-Access R&D Technology Leadership Award from Frost & Sullivan

We are thrilled to share with you that we have been awarded the 2015 Frost & Sullivan North American Open-Access R&D Technology Leadership Award.  The award is part of Frost &...

Global WuXi Webinar: Pioneering Approaches to Dismantling Cancer

Significant advances have been made to unravel cancer’s mysteries and complexities at the genetic, molecular, and pathway levels. These advances not only reveal new scientific insights into the biology of the...



Twitter LinkedIn 


WuXi NextCODE Completes $240 Million Series B Financing

We are pleased to announce that WuXi NextCODE has successfully completed a $240 million Series B financing. The company extended and completed the Series...